PRESS RELEASE published on 08/04/2026 at 22:03, 10 days 5 hours ago #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised Fresenius SE & Co. KGaA demonstrates excellent Q2 performance with structural step-up, leading to raised guidance. Core EPS grows by 14% and EBIT by 10%, reflecting operational strength and earnings quality improvement Q2 Performance Operational Strength Fresenius SE Structural Step-up Core EPS Growth
PRESS RELEASE published on 08/04/2026 at 22:01, 10 days 5 hours ago EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance Fresenius SE & Co. KGaA raises earnings guidance for FY 2026 by 10%-15% due to strong operational performance. Group revenue up 6% organically in Q2/26 Operational Performance Group Revenue Earnings Guidance Fresenius FY 2026
BRIEF published on 07/23/2026 at 10:05, 22 days 17 hours ago Fresenius lance un fonds d'investissement de 200 millions d'euros pour l'innovation dans le secteur de la santé Fresenius Innovation Dans Le Secteur De La Santé Michael Sen Thomas Thestrup Fonds De Capital-risque
BRIEF published on 07/23/2026 at 10:05, 22 days 17 hours ago Fresenius Launches €200 Million Venture Fund for Healthcare Innovation Healthcare Innovation Venture Fund Fresenius Michael Sen Thomas Thestrup
PRESS RELEASE published on 07/23/2026 at 10:00, 22 days 17 hours ago Fresenius establishes venture fund of more than €200 million to drive healthcare innovation Fresenius establishes venture fund of over €200 million to drive healthcare innovation, targeting growth fields adjacent to existing platforms, led by Dr. Thomas Thestrup from Angelini Ventures Healthcare Innovation Venture Fund Fresenius Thomas Thestrup Angelini Ventures
BRIEF published on 05/22/2026 at 16:49, 2 months 23 days ago Assemblée générale annuelle de Fresenius 2026 : Les actionnaires approuvent toutes les propositions Gouvernance D'Entreprise Approbation Des Actionnaires Restructuration Du Capital Annonce De Dividendes Assemblée Générale Annuelle De Fresenius
BRIEF published on 05/22/2026 at 16:49, 2 months 23 days ago Fresenius 2026 AGM: Shareholders Greenlight All Proposals Shareholder Approval Corporate Governance Dividend Announcement Capital Restructuring Fresenius AGM
PRESS RELEASE published on 05/22/2026 at 16:44, 2 months 23 days ago 2026 Annual General Meeting of Fresenius: Shareholders approve all agenda items Shareholders of Fresenius SE & Co. KGaA approve all agenda items at 2026 Annual General Meeting. Dividend of €1.05 per share agreed. Majority votes in favor of financial proposals Shareholders Dividend AGM Approval Fresenius
BRIEF published on 05/22/2026 at 10:05, 2 months 23 days ago Fresenius Proposes 5% Dividend Increase Amid Strong 2025 Performance Dividend Increase Healthcare Innovation Fresenius 2025 Financial Performance Digitalization Strategies
BRIEF published on 05/22/2026 at 10:05, 2 months 23 days ago Fresenius propose une augmentation de dividende de 5 % suite à de solides performances en 2025 Augmentation Des Dividendes Fresenius Performance Financière 2025 Innovation Dans Le Secteur De La Santé Stratégies De Numérisation
Published on 08/15/2026 at 00:50, 2 hours 36 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 3 hours 11 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 3 hours 41 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:00, 4 hours 26 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 9 hours 11 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 11 hours 21 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 11 hours 57 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 9 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 9 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 9 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 9 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 9 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026